— Subsequent clinical trials expected to commence in 2020 — BURLINGAME, Calif.–(BUSINESS WIRE)–October 22, 2020– Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Cala Trio™ for the treatment of action tremors in the hands of […]